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Purpose The primary aims of this study are to: 1) compare carotid intima media thickness 
(CIMT) of young males who are habitual snorers compared to those who do not snore; 2) 
to compare CIMT between snorers and non-snorers to the intima media thickness (IMT) 
of the brachial artery, the control, that is not exposed to the vibrations from snoring; and 
3) to determine the risk for developing obstructive sleep apnea (OSA) in snorers 
compared to non-snorers through the use of validated questionnaires. Methods Subjects 
were classified as snorers (n=17) or non-snorers (n=6) according to the prescreening 
questionnaire. Height, weight, neck and waist circumferences, body composition, 
physical activity level, heart rate variability and accelerometer data were collected on 
each subject. Brachial and carotid IMT was imaged via ultrasonography; IMT 
measurements were compared between groups using brachial IMT as the control to 
compare CIMT between groups. Results No significant group differences were noted for 
any study variable, however a correlation was found between CIMT and physical activity 
(PA) (expressed as MET-min/wk) (r=0.65, p = .001). After controlling for PA, mean 
CIMT was greater in snorers compared to non-snorers (0.367 mm vs. 0.310 mm 
respectively; p=.014).  Brachial IMT did not differ between groups. Questionnaire data 
showed that 58.8% of snorers were at high risk for developing OSA compared to 0% for 
non-snorers. Conclusion Results suggest that the vibrations from snoring may contribute 
to vascular remodeling in the carotid artery, and may be an early mechanism contributing 
to the development of endothelial dysfunction, and early subclinical sign of CVD risk in 







 Obstructive sleep apnea (OSA) is a common sleep disorder, characterized by 
interrupted ventilation during sleep combined with excessive daytime sleepiness [1]. 
OSA affects an estimated 15 million adult Americans and is considered the most 
prevalent form of sleep-disordered breathing [1, 2]. Despite the high prevalence of OSA, 
it is estimated that as many as 80-90% of those 15 million individuals with OSA remain 
undiagnosed [1, 3-5]. OSA is defined as the intermittent cessation of breathing caused by 
complete (apnea) or partial (hypopnea) collapse of the airway due to an imbalance of 
forces in the pharynx during sleep [6]. Apnea is the complete cessation of airflow for ≥ 
10 seconds due to complete collapse of the airway and hypopnea is a ≥ 50% reduction in 
airflow for ≥ 10 seconds or ≥ 30% reduction in airflow accompanied by a ≥ 4% decrease 
in oxygen saturation due to partial collapse of the airway [1]. The reduced airflow and 
decreased oxygen saturation create conditions of hypoxemia and hypercapnia as 
ventilation becomes inadequate to meet the metabolic demands of the body. Hypoxemic 
and hypercapnic conditions stimulate the peripheral chemoreceptors located in the carotid 
bodies of the internal carotid arteries to transmit signals to the central nervous system to 
increase sympathetic nervous system (SNS) activity. As a result, the interrupted breathing 
event is terminated and normal ventilation is reestablished [7]. The individual cycles 
between sleep and wakefulness as the SNS is repeatedly stimulated, resulting in the 




continuously and restoratively throughout the night often results in excessive daytime 
sleepiness, a key symptom of OSA [6]. 
The pathophysiology of OSA is complex; a variety of factors predispose to upper 
airway narrowing and collapse during sleep within an individual [8].  Factors 
predisposing one to OSA include mechanical properties and collapsibility of the upper 
airway, ability to reflexively activate pharyngeal muscles, respiratory control system 
stability, decreased lung volume, and the predisposition to awakening during sleep [1, 9]. 
The upper airspace region of the pharynx, the pharyngeal airway, is composed of 
muscular and soft tissues in contrast to other regions of the respiratory tract such as the 
trachea and bronchi that are surrounded by more rigid, cartilaginous support [9]. The 
plasticity of the pharyngeal airway allows for essential, non-respiratory functions such as 
speaking, chewing, and swallowing [9]. However, its collapsibility presents a potential 
problem for the essential respiratory function of the upper airway because the passage 
must remain open during breathing to allow for sufficient ventilation and gas exchange 
[9]. Sleep, especially rapid eye movement (REM) sleep, causes reductions in muscular 
tone of the pharyngeal airway, resulting in narrowing of the airway and increased 
resistance to airflow [10]. These changes contribute significantly to hypoventilation and 
increased arterial Pco2 in normal sleeping subjects [11].  
The primary abnormality in patients with OSA is an anatomically small 
pharyngeal airway resulting from obesity and/or bone and soft tissue structures [1]. 
Obesity causes dynamic loading of the airway due to the weight of fatty tissue in the 
neck, resulting in minor collapse [12]. When awake, OSA patients experience increased 




response to the negative pressure, mechanoreceptors, located primarily in the larynx, 
increase activity of pharyngeal dilatory muscles, thereby maintaining airway patency 
while awake [1]. In individuals with already anatomically narrow airways, the 
suppressant effects of sleep on pharyngeal muscle tone predisposes them to airflow 
limitations (snoring and hypopneas) and complete airway closures (obstructive apneas) 
[9]. During sleep, the reflex pharyngeal muscle activity that drives this neuromuscular 
compensation is reduced or lost, leading to pharyngeal narrowing and intermittent 
complete collapse [1]. Resulting apneas or hypopneas stimulate effort to breath and 
ultimately arouse the individual from sleep to terminate the apneic event [1]. Thus, an 
upper airway that requires reflex driven muscle activation to remain open during the 
wakefulness may be at risk for collapse during sleep [1].  
Large population studies have helped to establish numerous demographic 
correlates and risk factors for OSA [5, 13]. OSA is more prevalent in males than females, 
with a patient case ratio of 8:1 [4]. Sex differences in the diagnosis of OSA are attributed 
to differences in clinical presentation and differences in pathophysiology [14]. It is also 
thought that sex differences in prevalence may be explained by the likelihood that women 
are under diagnosed with OSA due different expression of clinical symptoms [16]. Men 
usually present with typical symptoms such as snoring or daytime sleepiness, while 
women are more likely to present atypical symptoms of insomnia or fatigue or have 
concomitant clinical depression or hypothyroidism [15]. Atypical symptoms in women 
compared to men can cause diversion from the OSA diagnosis.  Mechanisms that are 
thought to play a role in the prevalence of OSA diagnosis between sexes include 




[17]. The prevalence of OSA increases with age; with a 2 to 3 fold higher prevalence in 
older individuals (>65 years old) compared with those in middle age (30-64 years old) 
[4]. As with many other chronic diseases, OSA risk increases with age due to 
physiological mechanism related to aging and due to increased risk for developing CVD 
with age. OSA and CVD are strongly associated together, for example, atrial fibrillation 
and congestive heart failure are considered risk factors for developing OSA; risk for both 
of these diseases increases with age [18].   
Established risk factors for OSA include habitual snoring, overweight and obesity, 
central body fat distribution, large neck girth, and craniofacial and upper airway 
abnormalities [4]. There is a graded increase in OSA prevalence with increasing body 
mass index, neck circumference, and waist to hip ratio [4]. Craniofacial and upper airway 
structure play an important role in the occurrence of OSA, as these contribute to the 
anatomy and potential narrowing of the upper airway [4, 9]. In addition, suspected risk 
factors for OSA include genetics, smoking, menopause, alcohol use before sleep, and 
nighttime nasal congestion [4]. Several studies have shown an increased risk of OSA in 
families of patients with the breathing disorder [4]. This association may suggest that risk 
factors come from similar lifestyles or may indicate a genetic basis to OSA [5]. Smoking 
is a possible risk factor; however, this has only been reported in few studies. Possible 
mechanisms for the role of smoking include airway inflammation, smoking related 
diseases, and declining blood nicotine levels on sleep stability [4]. Hormonal differences 
are believed to account for the sex difference in OSA prevalence. Because sex hormone 
levels change dramatically with menarche, pregnancy, and menopause, it is plausible that 




alcohol on apnea and hypopnea frequency but the effect of long-term alcohol use on the 
development or progression of OSA is unknown [5]. Nasal congestion at night, whether 
due to allergies, acute upper respiratory tract infection, or anatomy, has been linked to 
snoring and OSA in both experimental and epidemiological studies [5]. OSA patients 
also exhibit higher prevalence of hypertension, type II diabetes, cardiovascular disease, 
and stroke compared to those without OSA [1, 18-24]. 
The physiological mechanisms linking OSA to other chronic diseases are complex 
and inadequately understood. However, autonomic dysregulation and endothelial 
dysfunction provide key explanations for the association between OSA and chronic 
disease [1, 25-32].  The first mechanism listed above, autonomic dysregulation, has many 
mechanisms are thought to contribute to it; these include hyperleptinemia, increased 
sympathetic activity, systemic inflammation, oxidative stress, and impaired baroreflex 
[12]. OSA-related oxygen desaturation and accompanying apnea/hypopnea events 
promote degenerative remodeling of the arterial wall and may be an early sign of 
subclinical atherosclerosis [20, 22, 33-35]. The extent of hypertrophy damage in the 
carotid artery caused by remodeling appears to correlate with frequency and intensity of 
hypoxemia [34]. Measurement of the thickness of the intima-media layer of the carotid 
artery (CIMT), through ultrasound imaging, has been demonstrated to be a valid and 
dependable non-invasive marker of subclinical atherosclerosis [36, 37]. CIMT thickness 
indicates a higher level of CVD risk by indicating the presence of early atherosclerosis 
and wall hypertrophy [34].  
A second plausible mechanism is autonomic dysregulation induced by 




appears to be significant in determining development of atherosclerosis independent of 
traditional CVD risk factors [36-42]. Heart rate variability (HRV) is a measure of 
autonomic effect on the heart; OSA patients have been shown to have varying levels of 
sympathetic stimulation corresponding to O2 levels that cause respective changes in heart 
rate [43]. Autonomic function impairment indicates severity of hypoxemia in OSA 
patients and is associated with HRV patterns [43].  Hypoxemia causes increased 
sympathetic stimulation due to chemoreceptor activation; this leads to vasoconstriction 
and increased arterial pressure that contribute to carotid wall damage [43, 44]. Previous 
studies based on muscle sympathetic nerve activity (MSNA) have shown increased 
sympathetic activity during sleep apneic events as well as a sustained increase in MSNA 
during daytime awake rest [7]. Another study focusing on the sympathetic system found 
patients with moderate to severe OSA to have a higher mean heart rate and reduced heart 
rate variability. Patients with reduced total variance in heart rate are commonly found to 
have some form of heart failure or dilated cardiomyopathy [45]. These authors suggest 
that the repetitive sympathetic activation and blood pressure surges that occur in response 
to apneic episodes during sleep might cause an impairment of baroreflex and other 
cardiovascular reflexes that carry over, even into daytime wakefulness [45].  
Previous studies have suggested that snoring and OSA may be important risk 
factors in the development of carotid atherosclerosis and stroke [46, 47]. A more recent 
study investigated whether snoring is an independent risk factor for developing carotid 
atherosclerotic plaque [22]. Heavy snoring was objectively measured and found to be a 
significant risk factor for the presence of atherosclerosis compared to participants who 




atherosclerotic risk factors and was independent of other measures of sleep-disordered 
breathing and hypoxia [22].  One study found that middle-aged patients with severe OSA, 
but without overt cardiovascular diseases, demonstrated early signs of atherosclerosis by 
means of increased arterial stiffness and carotid remodeling [20]. The experimental and 
control groups presented no differences in classical cardiovascular risk factors, the 
vascular abnormalities are independently associated with OSA [20].  
Atherosclerosis involves several interrelated processes including endothelial 
dysfunction, inflammation, oxidative stress, vascular smooth cell activation, platelet 
activation, and thrombosis. OSA is also associated with the majority of these factors; 
venous [48] and arterial [26, 30] endothelial dysfunction, systemic inflammation [13], 
increased levels of plasma VEGF (vascular endothelial growth factor) [25], reactive 
oxygen species [49], soluble adhesion molecules [50], coagulation factors [51], and 
endothelin-1 [32] have all been reported in patients with OSA. Each of these factors 
contributes to the development of atherosclerosis and CVD by extension in OSA patients 
and may help to explain the link between OSA and CVD. 
 The pathophysiological mechanism linking snoring, OSA, and stroke are still 
unclear and remain widely unexplored. Carotid atherosclerosis is a leading cause of 
stroke and is a complex disease involving several highly interrelated processes, including 
endothelial dysfunction, inflammation, oxidative stress, vascular smooth muscle cell 
activation, platelet activation, and thrombosis [35].  Recent studies have indicated that 
OSA is also associated with many of these processes [1, 7, 13, 24]. 
  In the absence of coexisting OSA, the prevailing view of snoring is that there is 




However, a recent study done by Lee, et al. (2008) identified heavy snoring, in the 
absence of hypoxemia, as an independent risk factor for carotid atherosclerosis. 
Vibration-induced endothelial dysfunction in rabbits provides a plausible 
pathophysiological mechanism linking snoring and localized carotid atherosclerosis [28, 
54]. Endothelial dysfunction plays a pivotal role in the early pathogenesis of 
atherosclerosis and can be detected through CIMT measurement in patients with sleep-
disordered breathing [28]. Self-reported snoring has been shown to be significantly 
associated with increased CIMT measures, independent of traditional CVD risk factors 
[23]. Studies to date have used middle aged and older males as participants; the extent to 
which CIMT remodeling occurs in young men is unknown. Identifying snoring in young 
men as an early marker of subclinical atherosclerosis could have substantial public health 
implications for the management and early detection in the cascade of events from 
habitual snorer, to OSA diagnosis, to overt CVD development [22].   
  
Purpose 
 The primary aims of this study are to: 1) compare carotid intima media thickness 
(CIMT) of young males who are habitual snorers compared to those who do not snore; 2) 
to compare CIMT between snorers and non-snorers to IMT of the brachial artery, the 
control, that is not exposed to the vibrations from snoring; and 3) to determine the risk for 
developing obstructive sleep apnea (OSA) in snorers compared to non-snorers through 







 Young males who habitually snore will have higher CIMT measurements 
compared to age-matched non-snorers. The relationship between CIMT and brachial IMT 
in snorers will demonstrate carotid endothelial dysfunction compared to non-snorers. 
Finally, validated questionnaires will indicate a greater risk for developing OSA in 
snorers compared to non-snorers.   
 
Limitations 
• The study included only those individuals classified as overweight-to-obese 
according to body mass index (BMI) classifications (overweight = BMI > 25 
kg/m2) 
• The snoring group consisted of college-aged males only, aged 18-26, with varying 
physical activity levels.  
• The potential effect of alcohol was not controlled for, however, anecdotally 
subjects who mentioned alcohol affecting their snoring were asked to abstain for 
the night they wore the accelerometer.  
 
Delimitations 
• Subjects must be non-smokers, free from any known form of CVD, pulmonary, or 
metabolic disease. 
• Subjects currently using medications that may influence the hemostatic regulations 





Significance of the Study 
 Snoring occurs commonly among the general population, it is estimated that as 
many as 47.7% of men and 33.6% of women snore [23]. Several studies have determined 
plausible mechanisms for snoring being an important, self-reported risk factor for 
atherosclerosis and eventually CVD [22, 23, 28, 54]. The vibrations to the carotid artery 
caused by snoring have been shown to be associated with endothelial dysfunction. In 
addition, habitual snorers have been found to have greater CIMT measures independent 
of other traditional CVD risk factors compared to non-snorers. This association has been 
observed in older and middle-aged males but no studies have been done on young males 
to date. This study will be the first to determine a potential association between snoring 
and CIMT; if a link can be established between young male habitual snorers and 
increased CIMT measurements then snoring could become a significant, self-
diagnosable, subclinical risk factor for atherosclerosis and CVD.       
  
Definition of Terms 
1. Apnea: Complete cessation of airflow for ≥ 10 seconds. 
2. Hypopnea: ≥ 50% reduction in airflow for ≥ 10 seconds or ≥ 30% reduction in 
airflow accompanied by a ≥ 4% decrease in oxygen saturation. 
3. Obstructive Sleep Apnea (OSA): A common sleep disorder characterized by 
repeated complete or partial upper airway obstructions during sleep which causes 
loud snoring, oxygen desaturation, exaggerated sympathetic nervous system 







 Twenty-three (23) males from the James Madison University (JMU) and 
Harrisonburg, Virginia communities were recruited for this study.  Subjects were non-
smokers, free from any known CVD, pulmonary, or metabolic disease.  The use of 
medications that may influence the hemostatic parameters under investigation were cause 
for exclusion from the study.  All subjects were classified as overweight-to-obese 
according to body mass index (BMI) classifications (overweight = BMI > 25 kg/m2) [55].  
Subjects were asked to report to the Human Performance Laboratory (HPL) on two 
consecutive days, for a total of two hours (one hour each visit). All subjects were given 
signed consent forms to read and sign that provided a comprehensive description of the 
study, the risks and benefits associated with the study, and explained how confidentiality 
would be maintained. All procedures were approved by the JMU Institutional Review 




A prescreening questionnaire was used to determine if volunteers met the subject criteria 
and it was used to classify subjects as ‘snorers’ or ‘non-snorers’. After consent was 
obtained, subjects were asked to complete a health history questionnaire providing basic 
health information and identifying any potential exclusion criteria. Subjects were then 




(Screening Tool for Obstructive Sleep apnea) questionnaire, and Epworth Sleepiness 
Scale to assess their risk factors for OSA, level of snoring, and level of daytime 
sleepiness respectively. To account for the impact of habitual physical activity, the 
International Physical Activity Questionnaire (IPAQ-SF) short form was used to assess 
current physical activity level in all subjects.  
Body Composition 
Upon completion of all the questionnaires, subjects had their body weight measured 
using a physician’s scale and recorded to the nearest 0.1 kg, and height measured and 
recorded to the nearest 0.5cm. Waist and neck circumference measurements were also 
taken according to the American College of Sports Medicine (ACSM) guidelines using a 
cloth tape measure with spring-loaded handle, to reduce compression of the skin [55]. 
Estimates of percent body fat were then made via dual-energy x-ray absorptiometryer 
(DEXA) (Delphi QDR; Hologic; Boston, MA). The DEXA scan consisted of total 
body/abdominal adiposity and bone density.  
 Resting Blood Pressure 
Following these tests, the subjects’ resting blood pressure was measured according to 
ACSM procedures [55]. 
Actigraph Sleep Assessment  
At the end of the first visit, subjects were instructed on proper setup and usage of the 
Actigraph accelerometer (GT-3X plus; Actigraph; Pensacola, FL), to wear while sleeping 
for one night outside the lab. This small, lightweight device was used to measure and 
store data about their movement during sleep. The accelerometer was worn on the 




Actigraph at night and record the times they went to bed and the time they got out of bed 
on a log sheet. Variables measured during sleep included sleep/wake activity, sleep onset, 
sleep latency, amount of sleep and sleep efficiency. Actilife 6 Data Analysis Software 
provided sleep-scoring values using several validated scoring algorithms.     
Visit 2 
Ultrasonography 
Subjects were asked to return to the HPL one day after the first visit to return the 
Actigraph device for data download and analysis. Subjects then underwent measurements 
of carotid intima media thickness (CIMT) and brachial artery wall thickness via 
ultrasonography (DC-6; Mindray; Mahwah, NJ). For the CIMT and brachial 
measurements, subjects were brought to a quiet room to lie supine for ten minutes.  After 
this time, a portable ultrasound machine and gel were used to obtain and save ultrasound 
images of the carotid and brachial arteries for later analysis. For the CIMT measurement, 
the participant was instructed to lie in a supine position with the head slightly extended 
and turned in the opposite direction of the carotid artery being studied. For the brachial 
measurement, the participant was asked to lay their arm supine on the table while images 
were saved. 
    Statistical Analysis 
All variables were compared using independent sample t-tests, to assess group 
differences of study variables.  Pearson correlations were calculated to identify potential 
relationships between CIMT, brachial artery wall thickness, and other study variables.  
Analysis of covariance (ANCOVA) was then employed to examine group differences 




significant correlation as the covariate.  For example, group difference in CIMT was used 
as the dependent variable and the significant correlation between CIMT and PA was used 














Association of Habitual Snoring with Carotid Intima-Media Thickness in Young Men 
 
Abstract 
Purpose The primary aims of this study are to: 1) compare carotid intima media thickness 
(CIMT) of young males who are habitual snorers compared to those who do not snore; 2) 
to compare CIMT between snorers and non-snorers to the intima media thickness (IMT) 
of the brachial artery, the control, that is not exposed to the vibrations from snoring; and 
3) to determine the risk for developing obstructive sleep apnea (OSA) in snorers 
compared to non-snorers through the use of validated questionnaires. Methods Subjects 
were classified as snorers (n=17) or non-snorers (n=6) according to the prescreening 
questionnaire. Height, weight, neck and waist circumferences, body composition, 
physical activity level, heart rate variability and accelerometer data were collected on 
each subject. Brachial and carotid IMT was imaged via ultrasonography; IMT 
measurements were compared between groups using brachial IMT as the control to 
compare CIMT between groups. Results No significant group differences were noted for 
any study variable, however a correlation was found between CIMT and physical activity 
(PA) (expressed as MET-min/wk) (r=0.65, p = .001). After controlling for PA, mean 
CIMT was greater in snorers compared to non-snorers (0.367 mm vs. 0.310 mm 
respectively; p=.014).  Brachial IMT did not differ between groups. Questionnaire data 
showed that 58.8% of snorers were at high risk for developing OSA compared to 0% for 




to vascular remodeling in the carotid artery, and may be an early mechanism contributing 
to the development of endothelial dysfunction, and early subclinical sign of CVD risk in 
those at high risk for OSA. 
 
Introduction 
 Obstructive sleep apnea (OSA) is a common sleep disorder that is characterized 
by interrupted ventilation during sleep combined with excessive daytime sleepiness [1]. 
OSA affects an estimated 15 million adult Americans and is considered the most 
prevalent form of sleep-disordered breathing [1, 2]. Despite the high prevalence of OSA, 
it is estimated that as many as 80-90% of those 15 million individuals with OSA remain 
undiagnosed [1, 3-5]. OSA is defined as the intermittent cessation of breathing caused by 
complete (apnea) or partial (hypopnea) collapse of the airway due to an imbalance of 
forces in the pharynx during sleep [6]. Apnea is defined as the complete cessation of 
airflow for ≥ 10 seconds due to complete collapse of the airway and hypopnea is defined 
as ≥ 50% reduction in airflow for ≥ 10 seconds or ≥ 30% reduction in airflow 
accompanied by a ≥ 4% decrease in oxygen saturation due to partial collapse of the 
airway [1]. The reduced airflow and decreased oxygen saturation create conditions of 
hypoxemia and hypercapnia as ventilation becomes inadequate to meet the metabolic 
demands of the body. Hypoxemic and hypercapnic conditions stimulate the peripheral 
chemoreceptors located in the carotid bodies of the internal carotid arteries to transmit 
signals to the central nervous system to increase sympathetic nervous system (SNS) 
activity. As a result, the interrupted breathing event is terminated and normal ventilation 




repeatedly stimulated and, as a result, the pattern of hypoxemia and hypercapnia persists 
[7]. The inability to sleep continuously and restoratively throughout the night often 
results in excessive daytime sleepiness, a key symptom of OSA [6]. 
 Several risk factors for developing OSA have been determined; factors include 
habitual snoring, obesity (defined by a body mass index [BMI] > 28 kg/m2), age ≥ 40 
years, male gender, enlarged neck size, hypertension, and upper airway abnormalities [8]. 
Structural abnormalities can contribute to reductions in airway patency and include 
narrow nasal cavity, macroglossia (large tongue), retrognathia (posterior positioning of 
the mandible), micrognathia (undersized jaw), and excessive pharyngeal soft tissue. [2, 4, 
8-11]. Other potential risk factors for OSA include smoking, alcohol consumption, post-
menopausal hormonal status, and African American ethnicity [8]. However, further 
research is required regarding these potential risk factors, as they do not currently have 
sufficient evidence supporting their contribution to the development of OSA.  
Numerous physiological consequences of decreased airflow and oxygen 
saturation affect not only the ability to sleep through the night but also day-to-day 
activities. Daily activities are affected by tiredness during wakeful hours, impaired 
cognitive function, and motor vehicle and occupational accidents [12]. OSA patients also 
exhibit higher prevalence of hypertension, type II diabetes, cardiovascular disease, and 
stroke [1, 9, 10, 13-17]. 
 The physiological mechanisms linking OSA to other chronic diseases are complex 
and inadequately understood. One proposed mechanism linking OSA to cardiovascular 
disease (CVD) is dysfunction of the vascular endothelium [1, 18-25]. OSA-related 




remodeling of the arterial wall and may be an early sign of subclinical atherosclerosis 
[10, 15, 26-28]. The extent of hypertrophy damage in the carotid artery caused by 
remodeling appears to correlate with frequency and intensity of hypoxemia [27]. 
Measurement of the thickness of the intima-media layer of the carotid artery (CIMT), 
through ultrasound imaging, has been demonstrated to be a valid and dependable non-
invasive marker of subclinical atherosclerosis [29, 30]. CIMT thickness indicates a higher 
level of CVD risk by indicating the presence of early atherosclerosis and wall 
hypertrophy [27].  
 A second plausible mechanism is autonomic dysregulation induced by 
hypoxemia. Many mechanisms are thought to contribute to autonomic dysregulation 
including hyperleptinemia, increased sympathetic activity, systemic inflammation, 
oxidative stress, and impaired baroreflex [31].  Severity of OSA measured by the 
frequency and intensity of hypoxemia appears to be significant in determining 
development of atherosclerosis independent of traditional CVD risk factors [29, 30, 32-
36]. Hypoxemia causes increased sympathetic stimulation due to chemoreceptor 
activation; this leads to vasoconstriction and increased arterial pressure that contribute to 
carotid wall damage [37, 38]. OSA leads to overall autonomic dysfunction; this has been 
demonstrated through heart rate variability (HRV), muscle sympathetic nerve 
measurement and catecholamine levels in patients [37].   
  In the absence of coexisting OSA, the prevailing view of snoring is that there is 
little evidence to support a pathological role in development of vascular disease [39, 40]. 
However, a recent study done by Lee, et al. (2008) identified that heavy snoring in the 




induced endothelial dysfunction in rabbits provides a plausible pathophysiological 
mechanism linking snoring and localized carotid atherosclerosis [21, 41]. Endothelial 
dysfunction plays a pivotal role in the early pathogenesis of atherosclerosis and can be 
detected through CIMT measurement in patients with sleep-disordered breathing [21]. 
Self-reported snoring has been shown to be significantly associated with increased CIMT 
measures, independent of traditional CVD risk factors [9]. Studies to date have used 
middle aged and older males as participants; the extent to which CIMT remodeling 
occurs in young men is unknown. Identifying snoring in young men as an early marker of 
subclinical atherosclerosis could have substantial public health implications for the 
management and early detection in the cascade of events from habitual snorer, to OSA 
diagnosis, to overt CVD development [10].  
The purposes of this study are to first, compare CIMT measurements of young 
males who are habitual snorers compared to those who do not snore. Second, to compare 
IMT measures of vessel health in the brachial artery, not exposed to vibrations caused by 
snoring, to CIMT measures. Brachial IMT will serve as control so that CIMT between 
groups can be compared. And third, to determine the likelihood of the presence of OSA 




 Twenty-three (23) males from the James Madison University (JMU) and 
Harrisonburg, Virginia communities were recruited for this study.  Subjects were non-




medications that may influence the hemostatic parameters under investigation were cause 
for exclusion from the study.  All subjects were classified as overweight-to-obese 
according to body mass index (BMI) classifications (overweight = BMI > 25 kg/m2) [42].  
Subjects were asked to report to the Human Performance Laboratory (HPL) on two 
separate occasions, on consecutive days, for a total of two hours (one hour each visit). All 
subjects were given signed consent forms to read and sign that provided a comprehensive 
description of the study, the risks and benefits associated with the study, and explained 
how confidentiality would be maintained. All procedures were approved by the JMU 




A prescreening questionnaire was used to determine if volunteers met the subject criteria 
and it was used to classify subjects as ‘snorers’ or ‘non-snorers’. After consent was 
obtained, subjects were asked to complete a health history questionnaire providing basic 
health information and identifying any potential exclusion criteria. Subjects were then 
asked to complete three additional questionnaires: the Berlin Questionnaire (BQ), STOP 
(Screening Tool for Obstructive Sleep apnea) questionnaire, and Epworth Sleepiness 
Scale (ESS) to assess their risk factors for OSA, level of snoring, and level of daytime 
sleepiness respectively. To account for the impact of habitual physical activity, the 
International Physical Activity Questionnaire (IPAQ-SF) short form was used to assess 






Upon completion of all the questionnaires, subjects had their body weight measured 
using a physician’s scale and recorded to the nearest 0.1 kg, and height measured and 
recorded to the nearest 0.5cm. Waist and neck circumference measurements were also 
taken according to the American College of Sports Medicine (ACSM) guidelines using a 
cloth tape measure with spring-loaded handle, to reduce compression of the skin [42]. 
Estimates of percent body fat were then made via dual-energy x-ray absorptiometryer 
(DEXA) (Delphi QDR; Hologic; Boston, MA).  
 Resting Blood Pressure 
Following these tests, the subjects’ resting blood pressure was measured according to 
ACSM procedures [42]. 
Actigraph Sleep Assessment  
At the end of the first visit, subjects were instructed on proper setup and usage of the 
Actigraph accelerometer (GT-3X plus; Actigraph; Pensacola, FL), to wear while sleeping 
for one night outside the lab. This small, lightweight device was used to measure and 
store data about their movement during sleep. The accelerometer was worn on the 
subjects’ non-dominant wrist during sleep. Subjects were instructed to wear the 
Actigraph at night and record the times they went to bed and the time they got out of bed 
on a log sheet. Variables measured during sleep included sleep/wake activity, sleep onset, 
sleep latency, amount of sleep and sleep efficiency. Actilife 6 Data Analysis Software 








Subjects were asked to return to the HPL one day after the first visit to return the 
Actigraph device for data download and analysis. Subjects then underwent measurements 
of carotid intima media thickness (CIMT) and brachial artery wall thickness via 
ultrasonography (DC-6; Mindray; Mahwah, NJ). For the CIMT and brachial 
measurements, subjects were brought to a quiet room to lie supine for ten minutes.  After 
this time, a portable ultrasound machine and gel were used to obtain and save ultrasound 
images of the carotid and brachial arteries for later analysis. For the CIMT measurement, 
the participant was instructed to lie in a supine position with the head slightly extended 
and turned in the opposite direction of the carotid artery being studied. For the brachial 
measurement, the participant was asked to lay their arm supine on the table while images 
were saved. Brachial IMT served as the control measurement to compare CIMT to 
determine if there was an effect from the vibrations of snoring. 
    Statistical Analysis 
All variables were compared using independent sample t-tests, to assess group 
differences of study variables.  Pearson correlations were calculated to identify potential 
relationships between CIMT, brachial artery wall thickness and other study variables.  
Analysis of covariance (ANCOVA) was then employed to examine group differences 
with CIMT or brachial artery wall thickness as the dependent variable, and any 
significant correlation as the covariate.  For example, group difference in CIMT was used 
as the dependent variable and the significant correlation between CIMT and PA was used 





 Twenty-three subjects were separated into two groups categorized by snorers and 
non-snorers. Characteristics of the two groups are presented in Table 1. The snorers and 
non-snorers groups did not differ in measures of age, body composition, cardiovascular 
health, physical activity, or sleep questionnaire results except for the STOP questionnaire. 
Of the snorers, ten out of seventeen (58.8%) were considered at ‘high risk’ for OSA 
according to the STOP questionnaire compared to 0% of the non-snorers were at high 
risk.  
CIMT 
 CIMT measurements did not differ between groups (p = .093). However, a 
significant positive correlation was noted between CIMT and PA, as expressed by MET-
min per week (Figure 2). After controlling for PA, CIMT was greater in the snorers vs. 
the non-snorers (Figure 3). Brachial artery wall thickness measurements did not differ 
between groups, and no correlation was noted with PA. 
 
Discussion 
The present study aimed to assess the association between self-reported snoring 
and subclinical carotid atherosclerosis in young males. The primary finding of this study 
is an increased CIMT in snorers compared to non-snorers after controlling for the effects 
of physical activity in young, male, overweight subjects without any known form of 
CVD.  Between groups, brachial artery measurements were not different; suggesting that 
endothelium dysfunction of the carotid artery may be caused by proximity to vibrations 




one’s age is considered ‘increased risk’ for CVD [43].  No subject in the current study 
met this criterion.  This is not surprising given the young age of our subjects.  However, 
our findings may indicate self-reported snoring in young males to be an early potential 
marker for long-term development of OSA and CVD. 
 Snoring is a well-established, independent risk factor for obstructive sleep apnea, 
but few studies have assessed the association between self-reported snoring and risk for 
OSA [8]. To evaluate this association, we used two separate questionnaires, the STOP 
Questionnaire and Epworth Sleepiness Scale (ESS) to assess level of risk for OSA and 
daytime sleepiness respectively. A high percentage of the snorers were at high risk for 
developing OSA according to the STOP Questionnaire; in comparison, zero percent of 
the non-snorers were indicated to be at high risk for OSA according the STOP 
Questionnaire. Therefore, based on results from the STOP questionnaire, young males 
who snore are at a greater risk for developing OSA compared to non-snorers. However, 
scores between groups did not differ on the ESS questionnaire indicating the risk for 
OSA was not different between snorers and non-snorers based on levels of excessive 
daytime sleepiness. Given our young, student population, it is not surprising that both 
groups indicated feeling drowsy during the day. It is likely that this daytime sleepiness is 
reflected by a student lifestyle of voluntarily restricted sleep, rather than the presence of 
OSA.  
 Many studies have investigated endothelial dysfunction as a plausible 
pathological mechanism linking OSA and CVD [19-26]. However, fewer studies have 
looked at the association between snoring and endothelial dysfunction [10, 21, 41] and no 




response to this, the present study found young male habitual snorers had significantly 
greater CIMT compared with non-snorers after adjusting for physical activity, suggesting 
endothelial dysfunction of the carotid artery. We believe this finding can be explained by 
a previously proposed mechanism, suggesting that energy from snoring vibrations is 
transmitted to the carotid artery resulting in vessel wall intima media damage remodeling 
[21]. Our finding that brachial measurements were not significantly different between 
groups supports this mechanism interpretation.  
Our study is one of many to determine a significant correlation between physical 
activity (PA) and carotid arterial wall thickness [44]. When combined, previous research 
using large sample sizes (>28,000 subjects) has found an inverse relationship between 
self-reported PA and CIMT [45-49]. Higher PA levels earlier in life are associated with 
attenuated increases in CIMT measured at three and six years later [45, 49]. However, a 
study done by Yamada et al. [50] using a small sample size (n=149) found no 
relationship between CIMT and PA level assessed using a non-specific questionnaire. It 
is important to note that self-reported PA questionnaires provide subjective data and are 
therefore limited by a weak correlation with direct measures of physical fitness [51]. 
Questionnaires may only provide meaningful data in large cohorts and with specifically 
designed instruments to measure PA; this may explain the inconsistent finding regarding 
the correlation [44].   
 Several potential mechanisms responsible for changes in arterial wall thickness in 
response to exercise training have been proposed [44]. Systemic shear stress plays an 
important role in the regulation of large artery remodeling [52] and the formation of 




[53]. Exercise is associated with an increase in systemic shear stress; this perhaps 
explaining the exercise training induced decrease in artery wall thickness [44]. High 
systemic sheer stress, such as what is found during exercise, helps to prevent carotid 
atherosclerotic plaques from forming in the arteries. Another potential mechanism is 
oxidative stress; when the production of reactive oxygen species (ROS) exceeds the 
efficiency of antioxidant defenses it causes endothelial dysfunction that contributes to the 
development of atherosclerosis [54, 55]. Exercise training is associated with antioxidant 
effects and therefore may lower oxidative stress and is associated with decreased arterial 
wall IMT [44, 56]. 
 Finally, inflammation is also a potential mechanism to explain the correlation 
between CIMT and PA given the importance of the inflammatory process in the 
development of atherosclerosis [44].  Exercise training is associated with anti-
inflammatory effects; therefore it is possible that exercise training may alter arterial wall 
thickness [44]. A study done by Goto et al. [57] found that the effect on arterial wall 
thickness is dependant on exercise training intensity. Mild and moderate intensity 
exercise did not show increased serum levels of pro-inflammatory markers, however, 
high intensity exercise did demonstrate a significant increase in serum pro-inflammatory 
markers and free radical formation [57]. Although the study did not measure CIMT it is 
reasonable to speculate that high intensity exercise would contribute to increased IMT 
measurements. Our study found a significant, positive correlation between PA and CIMT. 
Of the 23 total subjects, 11 were classified as having a high level of physical activity 




physical activity, our fining supports the inflammatory mechanism leading to increased 
arterial wall IMT.   
 This is the first study to determine an association between self-reported snoring 
and subclinical atherosclerosis in young males. However, a relatively small sample size 
was used and the extent to which these findings can be applied to females is unknown.   
A strength of the study was that outside factors that could affect CIMT such as PA, 
medication use, smoking, and other chronic diseases that could impact study variables 
were controlled for through strict exclusion criteria and statistical control. Future research 
should compare CIMT between varying levels of severity of snoring using a larger 
sample size to determine a stronger association. Additionally, overnight 
polysomnography with 12-lead EKG could be used to better determine the likelihood of 
OSA and detect heart rate variability patterns. Overall, the present study established self-
reported snoring as an early potential sign in the cascade of events from habitual snorer, 
to high risk for the development of OSA, to overt cardiovascular disease development. 
Self-reported snoring is inexpensive and minimally time consuming thus, may be helpful 
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Table 1. Subject Characteristics 
  Snorers (n=17) Non-Snorers (n=6) 
Age, yr. 20.2 (1.9) 20.0 (2.0) 
BMI, kg/m2 29.1 (2.9) 27.8 (2.7) 
Waist Circumference, cm 93.1 (11.3) 88.4 (5.6) 
Neck Circumference, cm 39.8 (1.8) 38.8 (1.1) 
Total Body Fat % 20.5 (7.4) 17.2 (3.2) 
Trunk Fat % 19.4 (8.9) 15.6 (3.1) 
Resting HR, BPM 67.2 (7.9) 63.0 (4.6) 
Systolic BP, mmHg 121.4 (6.0) 119 (5.8) 
Diastolic BP, mmHg 82.6 (6.6) 80.3 (2.9) 
Brachial Artery, mm .330 (.060) .330 (.040) 
IPAQ-SF,MET-min/wk 3328.5 (3038.2) 3675.8 (2417.5) 
Epworth Sleepiness Scale 10.2 (3.2) 9.5 (3.7) 
Sleep Latency, min. 5.43 (5.7) 2.00 (3.9) 
Sleep Efficiency, % 85.5 (12.1) 87.2 (7.7) 
Total Sleep Time, min. 325.8 (69.7) 386.4 (42.0) 
# of Awakenings per hour of 
sleep .412 (.245) .617 (.630) 
Values are means with SD in parentheses; n, no. of subjects; BMI, body mass index; HR, 











Figure 1. MET-min/wk. and CIMT Correlation. Note that MET-min/wk. was 






































	   	  	  
Figure 2. CIMT: carotid intima media thickness. Adjusted means after controlling for 
MET-min/wk, note that CIMT measures were significantly greater in snorers compared 





































































Subject	  ID____________________________________	   Date	  Completed	  ____/____/____	  
	  
Height	  (cm)	  ___________	  Weight	  (kg)	  _________	   Age	  _____	  
	  
Please	  choose	  the	  correct	  response	  to	  each	  question.	  
	  
Category	  1	  	  
	  
1. Do	  You	  Snore?	  
☐	  a.	  Yes	  
☐	  b.	  No	  
☐	  c.	  Don’t	  know	  
	  
If	  you	  snore:	  
	  
2. Your	  snoring	  is:	  
☐	  a.	  Slightly	  louder	  than	  breathing	  
☐	  b.	  	  As	  loud	  as	  talking	  
☐	  c.	  	  Louder	  than	  talking	  
☐	  d.	  	  Very	  loud	  –	  can	  be	  heard	  in	  	  
	   adjacent	  rooms	  
	  
3. How	  often	  do	  you	  snore?	  
☐	  a.	  	  Nearly	  every	  day	  
☐	  b.	  	  3-­‐4	  times	  a	  week	  
☐	  c.	  	  1-­‐2	  times	  a	  week	  
☐	  d.	  	  1-­‐2	  times	  a	  month	  
☐	  e.	  	  Never	  or	  nearly	  never	  
	  
4. Has	  your	  snoring	  every	  bothered	  
other	  people?	  
☐	  a.	  	  Yes	  
☐	  b.	  	  No	  
☐	  c.	  	  Don’t	  Know	  
	  
5. Has	  anyone	  noticed	  that	  you	  quit	  
Breathing	  during	  your	  sleep?	  
☐	  a.	  	  Nearly	  every	  day	  
☐	  b.	  	  3-­‐4	  times	  a	  week	  
☐	  c.	  	  1-­‐2	  times	  a	  week	  









6. How	  often	  do	  you	  feel	  tired	  or	  fatigued	  after	  you	  sleep?	  
☐	  a.	  	  Nearly	  every	  day	  
☐	  b.	  	  3-­‐4	  times	  a	  week	  
☐	  c.	  	  1-­‐2	  times	  a	  week	  
☐	  d.	  	  1-­‐2	  times	  a	  month	  
☐	  e.	  	  Never	  or	  nearly	  never	  
	  
7. During	  your	  waking	  time,	  do	  you	  feel	  tired,	  fatigued	  or	  not	  up	  to	  par?	  
☐	  a.	  	  Nearly	  every	  day	  
☐	  b.	  	  3-­‐4	  times	  a	  week	  
☐	  c.	  	  1-­‐2	  times	  a	  week	  
☐	  d.	  	  1-­‐2	  times	  a	  month	  
☐	  e.	  	  Never	  or	  nearly	  never	  
	  
8. Have	  you	  ever	  nodded	  off	  or	  fallen	  asleep	  while	  driving	  a	  vehicle?	  
☐	  a.	  Yes	  




9. How	  often	  does	  this	  occur?	  
☐	  a.	  	  Nearly	  every	  day	  
☐	  b.	  	  3-­‐4	  times	  a	  week	  
☐	  c.	  	  1-­‐2	  times	  a	  week	  
☐	  d.	  	  1-­‐2	  times	  a	  month	  




10. Do	  you	  have	  high	  blood	  pressure?	  
☐	  a.	  	  Yes	  
☐	  b.	  	  No	  














































Subject	  ID____________________________________	   Date	  Completed	  ____/____/____	  
	  
This	  questionnaire	  asks	  you	  to	  indicate	  the	  chances	  of	  you	  becoming	  drowsy	  during	  
hours	  of	  the	  day	  that	  you	  are	  not	  in	  bed	  sleeping.	  	  “How	  likely	  are	  you	  to	  doze	  off	  or	  fall	  
asleep	  in	  the	  following	  situations?”	  
	  
Use	  the	  following	  scale	  and	  indicate	  the	  most	  appropriate	  number	  for	  each	  situation.	  
	  
	   	   	   	   0	  =	  would	  never	  doze	  
	   	   	   	   1	  =	  slight	  chance	  of	  dozing	  
	   	   	   	   2	  =	  moderate	  chance	  of	  dozing	  
	   	   	   	   3	  =	  high	  chance	  of	  dozing	  
	  
	   Situation	   	   	   	   	   	   	   Chance	  of	  Dozing	  
	  
1.	   Sitting	  and	  reading	   	   	   	   	   	   	   _____	  
	  
2.	   Watching	  T.V.	   	   	   	   	   	   	   	   _____	  
	  
3.	   Sitting,	  inactive	  in	  a	  public	  place	  
	   (ex.	  	  Theatre	  or	  meeting)	   	   	   	   	   	   _____	  
	  
4.	   As	  a	  passenger	  in	  a	  car	  for	  
	   an	  hour	  without	  a	  break	   	   	   	   	   	   _____	  
	  
5.	   Lying	  down	  to	  rest	  in	  the	  afternoon	  
	   when	  circumstances	  permit	   	   	   	   	   	   _____	  
	  
6.	   Sitting	  and	  talking	  with	  someone	   	   	   	   	   _____	  
	  
7.	   Sitting	  quietly	  after	  a	  lunch	  without	  alcohol	   	   	   	   _____	  
	  
8.	   In	  a	  car,	  while	  stopped	  for	  a	  few	  minutes	  
	   in	  the	  traffic	   	   	   	   	   	   	   	   _____	  
	  











































TODAY’S	  DATE	  	  _______________________	  	  





	  	   	   	   Street	   	   	   	  City	  	  	   	   	   State	  	   	  
	   Zip	  	  
TELEPHONE:	  HOME/	  CELL	  _________/	  __________	  	  	  	  E-­‐MAIL	  ADDRESS	  	  _____	  
Person	  to	  contact	  in	  case	  of	  an	  emergency	  ______________	  Phone	  _________	  
(relationship)	  _______	  
	  
Have	  you	  ever	  been	  diagnosed	  with	  cardiovascular	  disease?	  	  	  	  	  	   YES	   	  	  	  	  NO	  
Have	  you	  ever	  been	  diagnosed	  with	  musculoskeletal	  disease?	  YES	   	  	  	  	  NO	  
Have	  you	  ever	  had	  any	  heart	  problems?	   	   	   	   	   YES	   	  	  	  	  NO	  
Have	  you	  ever	  had	  Asthma?	  	   	   	   	   	   	   YES	   	  	  	  	  NO	  
Have	  you	  ever	  been	  told	  by	  a	  doctor	  you	  should	  not	  exercise?	  YES	   	  	  	  	  NO	  
Are	  you	  taking	  any	  Prescription	  (include	  birth	  control	  pills)	  or	  Non-­‐Prescription	  
medications?	  Yes	  	  No	  
For	  each	  of	  your	  current	  medications,	  provide	  the	  following	  information:	  	  
MEDICATION	  	  	   Dosage-­‐	  times/	  day	  	  	  	  	  	  Time	  taken	  	  	  	  	  	  Years	  on	  medication	  	  	   	  






ACTIVITY	  LEVEL	  EVALUATION	  	  
What	  is	  your	  occupational	  activity	  level?	  	  	  	  	  Sedentary	  	  	  	  	  	  	  Light	  	  	  	  	  	  	  Moderate	  	  	  	  	  	  	  Heavy	  	  	  	  
Do	  you	  currently	  engage	  in	  vigorous	  physical	  activity	  on	  a	  regular	  basis?	  	  	  	  	  Yes	  	  	  	  	  	  	  No	  	  	  	  	  	  	  	  	  





	  	  	  How	  much	  time	  per	  day?	  	  	  	  	  <15	  min	  	  	  	  	  	  	  15-­‐30	  min	  	  	  	  	  	  	  30-­‐45	  min	  	  	  	  	  	  	  >60	  min	  	  	  	  
Do	  you	  engage	  in	  any	  recreational	  or	  leisure-­‐time	  physical	  activities	  on	  a	  regular	  basis?	  	  	  	  	  
Yes	  	  	  	  	  	  	  No	  	  	  	  
	  	  	  If	  so,	  what	  activities?	  
__________________________________________________________________	  
	  	  	  	  	  On	  average:	  	  How	  often?	  ________	  times/week;	  	  	  	  	  for	  how	  long?	  ____________	  
time/session	  	  
Do	  you	  ever	  have	  an	  uncomfortable	  shortness	  of	  breath	  during	  exercise	  or	  when	  doing	  
activities?	  	  	  	  	  Yes	  	  	  	  	  	  	  No	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You	  are	  being	  asked	  to	  volunteer	  for	  a	  research	  project	  conducted	  by	  Dr.	  Trent	  Hargens	  
from	  James	  Madison	  University	  entitled,	  “Association	  of	  habitual	  snoring	  with	  carotid	  
intima-­‐media	  thickness	  in	  young	  men”.	  
	  
The	  primary	  goals	  of	  this	  study	  is	  to	  examine	  whether	  the	  vibrations	  that	  come	  from	  
habitual	  snoring	  result	  in	  structural	  changes	  to	  the	  blood	  vessels	  in	  your	  neck	  that	  may	  
lead	  to	  early	  signs	  of	  cardiovascular	  disease,	  and	  to	  relate	  habitual	  snoring	  to	  risk	  for	  




You	  will	  be	  asked	  to	  visit	  the	  Human	  Performance	  Laboratory	  (Godwin	  209)	  2	  times,	  1	  –	  
2	  days	  apart.	  	  Your	  total	  time	  commitment	  for	  participation	  in	  this	  study	  will	  be	  
approximately	  2	  hours.	  	  In	  addition,	  you	  will	  be	  asked	  to	  wear	  a	  device	  on	  your	  wrist	  for	  
1	  night,	  while	  you	  sleep.	  	  This	  will	  be	  done	  in	  your	  own	  home.	  	  Detailed	  information	  on	  




Before	  any	  test	  is	  given,	  you	  will	  be	  asked	  to	  complete	  a	  screening	  form	  and	  an	  
informed	  consent,	  to	  insure	  that	  you	  meet	  the	  study	  criteria,	  that	  you	  do	  not	  have	  any	  
factors	  that	  would	  disqualify	  you	  from	  participation.	  	  Upon	  completion	  of	  the	  informed	  
consent,	  you	  will	  be	  asked	  to	  complete	  a	  short	  health	  history	  questionnaire	  providing	  
information	  about	  your	  characteristics	  and	  health.	  	  You	  will	  then	  be	  asked	  complete	  3	  
standardized	  questionnaires	  about	  snoring,	  the	  quality	  of	  your	  sleep,	  daytime	  
sleepiness,	  and	  risk	  for	  OSA.	  
	  
You	  will	  then	  have	  your	  height,	  weight,	  waist	  circumference	  and	  neck	  circumference	  
measured.	  	  After	  that,	  your	  body	  composition	  will	  be	  analyzed	  via	  a	  Dual-­‐energy	  x-­‐ray	  
absorptiometer	  (DEXA).	  	  The	  DEXA	  scan	  will	  allow	  us	  to	  measure	  your	  percent	  body	  fat	  
and	  the	  mineral	  content	  and	  density	  of	  your	  bones.	  	  The	  DEXA	  is	  much	  like	  an	  X-­‐ray	  
machine.	  	  The	  DEXA	  will	  scan	  your	  entire	  body	  very	  slowly;	  so,	  you	  will	  need	  to	  lie	  on	  a	  
table	  without	  moving	  for	  almost	  10	  minutes,	  while	  the	  DEXA	  is	  passed	  over	  your	  entire	  
body.	  	  You	  will	  feel	  no	  discomfort	  associated	  with	  this	  test.	  
	  
Following	  the	  DEXA	  scan,	  we	  will	  ask	  that	  you	  wear	  a	  heart	  rate	  monitor	  while	  lying	  
down	  in	  a	  darkened	  room	  for	  15	  minutes	  to	  get	  measures	  of	  your	  heart	  rate.	  	  We	  will	  




At	  the	  end	  of	  this	  first	  visit	  you	  will	  also	  be	  instructed	  on	  the	  proper	  use	  procedures	  for	  
wearing	  an	  accelerometer	  to	  monitor	  your	  sleep	  for	  1	  night.	  	  An	  accelerometer	  is	  a	  small	  
device	  that	  is	  to	  be	  worn	  on	  your	  wrist	  while	  in	  bed.	  	  You	  will	  also	  be	  asked	  to	  record	  the	  





One	  to	  two	  days	  after	  Visit	  1,	  you	  will	  be	  asked	  to	  return	  to	  Godwin	  209	  to	  return	  the	  
accelerometer	  and	  to	  complete	  the	  remaining	  tests	  for	  the	  study.	  	  You	  will	  be	  asked	  to	  
lie	  down	  in	  a	  quiet,	  darkened	  room	  for	  10	  minutes,	  after	  which	  an	  ultrasound	  probe	  
(with	  gel)	  will	  be	  placed	  on	  your	  neck	  and	  arm	  to	  get	  images	  of	  your	  blood	  vessels.	  	  After	  
this,	  a	  blood	  pressure	  cuff	  will	  be	  placed	  on	  your	  arm	  and	  inflated	  for	  a	  period	  of	  5	  
minutes.	  	  After	  5	  minutes,	  the	  blood	  pressure	  cuff	  will	  be	  released	  we	  will	  again	  collect	  
ultrasound	  images	  of	  the	  blood	  vessel	  in	  your	  arm.	  	  We	  will	  collect	  images	  for	  2	  minutes	  
after	  we	  release	  the	  blood	  pressure	  cuff.	  	  If	  at	  any	  point	  during	  the	  5	  minutes	  that	  the	  
blood	  pressure	  cuff	  is	  on	  your	  arm	  that	  you	  feel	  you	  need	  to	  stop	  the	  test,	  the	  




There	  are	  no	  risks	  associated	  with	  wearing	  an	  accelerometer.	  	  Also,	  there	  is	  no	  risk	  
associated	  with	  heart	  rate,	  carotid	  ultrasound,	  blood	  pressure,	  height,	  weight,	  and	  waist	  
and	  neck	  circumference	  measures.	  	  Measurements	  with	  associated	  risks	  include:	  	  the	  
DEXA	  scan	  and	  ultrasound	  blood	  pressure	  cuff	  procedure.	  	  	  
	  
The	  amount	  of	  radiation	  that	  you	  will	  receive	  in	  the	  DEXA	  exam	  is	  less	  than	  the	  amount	  
you	  will	  receive	  during	  a	  transatlantic	  flight,	  and	  is	  equal	  to	  about	  1/20	  of	  a	  chest	  x-­‐ray.	  
	  
The	  risks	  of	  the	  ultrasound	  blood	  pressure	  cuff	  procedure	  include	  discomfort	  often	  
described	  as	  your	  arm	  is	  “falling	  asleep”;	  there	  is	  a	  temporary	  reduction	  or	  loss	  of	  
feeling	  because	  the	  blood	  flow	  through	  the	  vessel	  is	  stopped	  for	  five	  minutes.	  	  There	  is	  




There	  is	  no	  guarantee	  that	  you	  will	  get	  any	  benefit	  from	  taking	  part	  in	  this	  study.	  	  
Benefits	  may	  include	  knowledge	  about	  your	  health	  status.	  	  You	  will	  receive	  information	  
on	  your	  body	  composition,	  including	  percent	  body	  fat	  and	  bone	  mineral	  density,	  an	  
assessment	  of	  your	  sleep	  quality	  and	  risk	  for	  sleep	  apnea,	  and	  an	  assessment	  of	  your	  
blood	  vessel	  health.	  	  Indirect	  benefits	  of	  participating	  in	  this	  study	  will	  be	  helping	  the	  
researchers	  better	  understand	  the	  relationship	  between	  habitual	  snoring,	  sleep	  apnea,	  







If	  you	  have	  any	  questions	  or	  concerns	  or	  you	  would	  like	  to	  receive	  a	  copy	  of	  the	  final	  
aggregate	  results	  of	  this	  study,	  please	  contact	  Dr.	  Trent	  Hargens	  at	  hargenta@jmu.edu	  
or	  (540)	  568-­‐5844.	  In	  the	  case	  of	  any	  immediate	  concerns	  or	  adverse	  reactions	  during	  
the	  study,	  contact	  Dr.	  Hargens	  on	  his	  cell	  phone	  (540)	  810-­‐1310.	  
	  
Questions	  about	  Your	  Rights	  as	  a	  Research	  Subject	  
Dr.	  David	  Cockley	  
Chair,	  Institutional	  Review	  Board	  






All	  data	  and	  results	  will	  be	  kept	  confidential.	  You	  will	  be	  assigned	  an	  identification	  code.	  
At	  no	  time	  will	  your	  name	  be	  identified	  with	  your	  individual	  data.	  The	  researcher	  retains	  
the	  right	  to	  use	  and	  publish	  non-­‐identifiable	  data.	  All	  data	  will	  be	  kept	  secured	  in	  a	  
locked	  cabinet.	  Final	  aggregate	  results	  will	  be	  made	  available	  to	  participants	  upon	  
request.	  
	  
Freedom	  of	  Consent	  
	  
Your	  participation	  is	  entirely	  voluntary.	  	  You	  are	  free	  to	  choose	  not	  to	  participate.	  	  
Should	  you	  choose	  to	  participate,	  you	  can	  withdraw	  at	  any	  time	  without	  consequences	  
of	  any	  kind.	  
	  
I	  have	  read	  this	  consent	  form	  and	  I	  understand	  what	  is	  being	  requested	  of	  me	  as	  a	  
participant	  in	  this	  study.	  	  I	  freely	  consent	  to	  participate.	  	  I	  have	  been	  given	  satisfactory	  
answers	  to	  my	  questions.	  	  The	  investigator	  provided	  me	  with	  a	  copy	  of	  this	  form.	  	  I	  
certify	  that	  I	  am	  at	  least	  18	  years	  of	  age.	  
	  
________________________________	   __________________________________	  
Name	  of	  Subject	  (Printed)	   	   Name	  of	  Researcher	  (Printed)	  
	  
________________________________	   __________________________________	  
Name	  of	  Subject	  (Signed)	   	   Name	  of	  Researcher	  (Signed)	  
	  
________________________________	   __________________________________	  































































Subject	  ID___________________________________	   Date	  Completed	  ____/____/____	  
	  
Height	  (Inches)	  ___________	   Weight	  (lbs)	  _________	   Age	  _____	  
	  
Neck	  Circumference	  (cm)	  ____________	  
	  
	  
The	  STOP	  Test	  consists	  of	  four	  questions:	  
	  
	  
1. Snoring	  	  
Do	  you	  snore	  loudly	  (louder	  than	  talking	  or	  loud	  enough	  to	  be	  heard	  through	  closed	  
door)?	  	  	   	   	   	   	   	   	   	   	   Yes	  No	  	  
	  
2. Tired	  	  
Do	  you	  often	  feel	  tired,	  fatigued	  or	  sleepy	  during	  the	  day?	  	  	   Yes	  No	  	  
	  
3. Observed	  	  
Has	  anyone	  observed	  you	  stop	  breathing	  during	  your	  sleep?	  	   Yes	  No	  	  
	  
4.	  Blood	  Pressure	  	  






High	  risk	  of	  OSA:	  answering	  yes	  to	  two	  or	  more	  questions	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